Total Funding
64
Total FundingGrant raised
Growth Score
pts
Heat Score
8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Monoclonals develops novel monoclonal antibodies for rapid tests which diagnose diseases, specifically for resource poor areas.
- Christine Soto: Founder, CEO
About the Company
Monoclonals develops novel monoclonal antibodies for rapid tests which diagnose diseases, specifically for resource poor areas. Founded in 2016 by Christine Soto, Monoclonals is currently registered with National Institute of Health (NIH) for the purpose of obtaining a grant which will help develop novel rapid test kits for diagnostic purposes. The
company is privately funded and at product development phase.
Women Founded
